You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 354 A phase 1 trial of CUE-101 a novel HPV16 E7-pHLA-IL2-Fc fusion protein in patients with recurrent/metastatic HPV16+ head and neck cancer

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
354 A phase 1 trial of CUE-101 a novel HPV16 E7-pHLA-IL2-Fc fusion protein in patients with recurrent/metastatic HPV16+ head and neck cancer

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020153016
Dec 202052045
Jan 202122012
Feb 20211602
Mar 20215009
Apr 20214403
May 202116011
Jun 2021004
Jul 2021009
Aug 2021005
Sep 2021005
Oct 202150017
Nov 2021151020
Dec 202110805
Jan 202213605
Feb 202211005
Mar 202211603
Apr 202213806
May 202210807
Jun 202210804
Jul 202211002
Aug 202211608
Sep 20227002
Oct 202210004
Nov 202210002
Dec 20228201
Jan 20237001
Feb 20236200
Mar 20236802
Apr 20237403
May 20236400
Jun 20237403
Jul 20235803
Aug 20237601
Sep 20236602
Oct 20237003
Nov 20235803
Dec 20237600
Jan 20245800
Feb 20247202
Mar 20247600
Apr 20245401
May 20243801
Jun 20244403
Jul 20245002
Aug 20244001
Sep 20243401
Oct 20243204
Nov 20243402
Dec 20244606
Jan 20251806
Feb 2025203
Mar 2025001
Apr 2025003
May 2025003
Jun 2025004
Total33700276